Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Escape of SARS-CoV-2 501Y.V2 from neutralization by convalescent plasma

Sandile Cele, Inbal Gazy, Laurelle Jackson, Shi-Hsia Hwa, Houriiyah Tegally, Gila Lustig, Jennifer Giandhari, Sureshnee Pillay, Eduan Wilkinson, Yeshnee Naidoo, Farina Karim, Yashica Ganga, Khadija Khan, Mallory Bernstein, View ORCID ProfileAlejandro B. Balazs, Bernadett I. Gosnell, Willem Hanekom, Mahomed-Yunus S. Moosa, NGS-SA, COMMIT-KZN Team, Richard J. Lessells, View ORCID ProfileTulio de Oliveira, Alex Sigal
doi: https://doi.org/10.1101/2021.01.26.21250224
Sandile Cele
1Africa Health Research Institute, Durban 4001, South Africa
2School of Laboratory Medicine and Medical Sciences, University of KwaZulu-Natal, Durban 4001, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Inbal Gazy
2School of Laboratory Medicine and Medical Sciences, University of KwaZulu-Natal, Durban 4001, South Africa
3KwaZulu-Natal Research Innovation and Sequencing Platform, Durban 4001, South Africa
4Department of Biochemistry and Molecular Biology, The Institute for Medical Research Israel-Canada, Hadassah Medical School, The Hebrew University of Jerusalem, 91120, Jerusalem, Israel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Laurelle Jackson
1Africa Health Research Institute, Durban 4001, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shi-Hsia Hwa
1Africa Health Research Institute, Durban 4001, South Africa
5Division of Infection and Immunity, University College London, London WC1E 6BT, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Houriiyah Tegally
3KwaZulu-Natal Research Innovation and Sequencing Platform, Durban 4001, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gila Lustig
6Centre for the AIDS Programme of Research in South Africa, Durban 4001, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jennifer Giandhari
3KwaZulu-Natal Research Innovation and Sequencing Platform, Durban 4001, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sureshnee Pillay
3KwaZulu-Natal Research Innovation and Sequencing Platform, Durban 4001, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eduan Wilkinson
3KwaZulu-Natal Research Innovation and Sequencing Platform, Durban 4001, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yeshnee Naidoo
3KwaZulu-Natal Research Innovation and Sequencing Platform, Durban 4001, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Farina Karim
1Africa Health Research Institute, Durban 4001, South Africa
2School of Laboratory Medicine and Medical Sciences, University of KwaZulu-Natal, Durban 4001, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yashica Ganga
1Africa Health Research Institute, Durban 4001, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Khadija Khan
1Africa Health Research Institute, Durban 4001, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mallory Bernstein
1Africa Health Research Institute, Durban 4001, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alejandro B. Balazs
7Ragon Institute of MGH, Harvard, and MIT, Cambridge, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Alejandro B. Balazs
Bernadett I. Gosnell
8Department of Infectious Diseases, Nelson R. Mandela School of Clinical Medicine, University of KwaZulu-Natal, Durban 4001, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Willem Hanekom
1Africa Health Research Institute, Durban 4001, South Africa
5Division of Infection and Immunity, University College London, London WC1E 6BT, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mahomed-Yunus S. Moosa
8Department of Infectious Diseases, Nelson R. Mandela School of Clinical Medicine, University of KwaZulu-Natal, Durban 4001, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Richard J. Lessells
2School of Laboratory Medicine and Medical Sciences, University of KwaZulu-Natal, Durban 4001, South Africa
3KwaZulu-Natal Research Innovation and Sequencing Platform, Durban 4001, South Africa
6Centre for the AIDS Programme of Research in South Africa, Durban 4001, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tulio de Oliveira
2School of Laboratory Medicine and Medical Sciences, University of KwaZulu-Natal, Durban 4001, South Africa
3KwaZulu-Natal Research Innovation and Sequencing Platform, Durban 4001, South Africa
6Centre for the AIDS Programme of Research in South Africa, Durban 4001, South Africa
9Department of Global Health, University of Washington, Seattle, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Tulio de Oliveira
  • For correspondence: deoliveira@ukzn.ac.za alex.sigal@ahri.org
Alex Sigal
1Africa Health Research Institute, Durban 4001, South Africa
2School of Laboratory Medicine and Medical Sciences, University of KwaZulu-Natal, Durban 4001, South Africa
10Max Planck Institute for Infection Biology, Berlin 10117, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: deoliveira@ukzn.ac.za alex.sigal@ahri.org
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

SARS-CoV-2 variants of concern (VOC) have arisen independently at multiple locations and may reduce efficacy of current vaccines targeted at the spike glycoprotein. We re-cently described the emergence of VOC in South Africa (501Y.V2 or PANGO lineage B.1.351) with mutations in the spike receptor-binding domain (RBD) and N-terminal domain (NTD). Here, using a live virus neutralization assay (LVNA), we compared neutralization of a first wave virus (B.1.1.117) versus the 501Y.V2 variant using plasma collected from adults hospitalized with COVID-19 from two South African infection waves, with the second wave dominated by 501Y.V2 infections. Sequencing demonstrated that infections in first wave plasma donors were with viruses harbouring none of the 501Y.V2-defining RBD or NTD mutations, except for one with E484K. 501Y.V2 virus was effectively neutralized by plasma from second wave infections and first wave virus was effectively neutralized by first wave plasma. In cross-neutralization, 501Y.V2 virus was poorly neutralized by first wave plasma, with an 8.4-fold drop in neutralization relative to first wave virus and a 15.1-fold drop relative to 501Y.V2 neutralization by second wave plasma. In contrast, second wave plasma neutralization of first wave virus was more effective, showing 4.1-fold decline relative to 501Y.V2 virus neutralization and 2.3-fold decline relative to first wave plasma neutralization. While we only tested one plasma elicited by E484K alone, this potently neutralized both variants. The observed effective neutralization of first wave virus by 501Y.V2 infection elicited plasma provides preliminary evidence that vaccines based on VOC sequences could retain activity against other circulating SARS-CoV-2 lineages.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This work was supported by the Bill and Melinda Gates Investment INV-018944 (AS) and by the South African Medical Research Council and the Department of Science and Innovation (TdO).

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Nasopharyngeal/oropharyngeal swab samples and plasma samples were obtained from six hospitalized adults with PCR-confirmed SARS-CoV-2 infection enrolled in a prospective cohort study ap- proved by the Biomedical Research Ethics Committee (BREC) at the University of KwaZulu-Natal (reference BREC/00001275/2020). The 501Y.V2 variants were obtained from residual nasopharyngeal/oropharyngeal samples used for routine SARS-CoV-2 diagnostic testing by the National Health Laboratory Service, through our SARS-CoV-2 genomic surveillance program (BREC approval reference BREC/00001510/2020).

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • This version was revised followed first round of reviewers of Nature. Figure 1, Figure 2 and Figure 3 were updated and contains more experimental data with viruses from the 501Y.V2 (B.1.351) variant.

Data Availability

All sequence data is available at GISAID.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Back to top
PreviousNext
Posted February 27, 2021.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Escape of SARS-CoV-2 501Y.V2 from neutralization by convalescent plasma
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Escape of SARS-CoV-2 501Y.V2 from neutralization by convalescent plasma
Sandile Cele, Inbal Gazy, Laurelle Jackson, Shi-Hsia Hwa, Houriiyah Tegally, Gila Lustig, Jennifer Giandhari, Sureshnee Pillay, Eduan Wilkinson, Yeshnee Naidoo, Farina Karim, Yashica Ganga, Khadija Khan, Mallory Bernstein, Alejandro B. Balazs, Bernadett I. Gosnell, Willem Hanekom, Mahomed-Yunus S. Moosa, NGS-SA, COMMIT-KZN Team, Richard J. Lessells, Tulio de Oliveira, Alex Sigal
medRxiv 2021.01.26.21250224; doi: https://doi.org/10.1101/2021.01.26.21250224
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Escape of SARS-CoV-2 501Y.V2 from neutralization by convalescent plasma
Sandile Cele, Inbal Gazy, Laurelle Jackson, Shi-Hsia Hwa, Houriiyah Tegally, Gila Lustig, Jennifer Giandhari, Sureshnee Pillay, Eduan Wilkinson, Yeshnee Naidoo, Farina Karim, Yashica Ganga, Khadija Khan, Mallory Bernstein, Alejandro B. Balazs, Bernadett I. Gosnell, Willem Hanekom, Mahomed-Yunus S. Moosa, NGS-SA, COMMIT-KZN Team, Richard J. Lessells, Tulio de Oliveira, Alex Sigal
medRxiv 2021.01.26.21250224; doi: https://doi.org/10.1101/2021.01.26.21250224

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (159)
  • Allergy and Immunology (412)
  • Anesthesia (90)
  • Cardiovascular Medicine (854)
  • Dentistry and Oral Medicine (156)
  • Dermatology (97)
  • Emergency Medicine (247)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (392)
  • Epidemiology (8533)
  • Forensic Medicine (4)
  • Gastroenterology (381)
  • Genetic and Genomic Medicine (1735)
  • Geriatric Medicine (166)
  • Health Economics (370)
  • Health Informatics (1232)
  • Health Policy (616)
  • Health Systems and Quality Improvement (467)
  • Hematology (196)
  • HIV/AIDS (368)
  • Infectious Diseases (except HIV/AIDS) (10264)
  • Intensive Care and Critical Care Medicine (551)
  • Medical Education (192)
  • Medical Ethics (51)
  • Nephrology (209)
  • Neurology (1664)
  • Nursing (97)
  • Nutrition (247)
  • Obstetrics and Gynecology (323)
  • Occupational and Environmental Health (450)
  • Oncology (922)
  • Ophthalmology (261)
  • Orthopedics (100)
  • Otolaryngology (172)
  • Pain Medicine (110)
  • Palliative Medicine (40)
  • Pathology (249)
  • Pediatrics (532)
  • Pharmacology and Therapeutics (245)
  • Primary Care Research (205)
  • Psychiatry and Clinical Psychology (1753)
  • Public and Global Health (3818)
  • Radiology and Imaging (621)
  • Rehabilitation Medicine and Physical Therapy (317)
  • Respiratory Medicine (518)
  • Rheumatology (206)
  • Sexual and Reproductive Health (164)
  • Sports Medicine (156)
  • Surgery (189)
  • Toxicology (36)
  • Transplantation (99)
  • Urology (74)